Fonar ROE 2010-2024 | FONR
Current and historical return on equity (ROE) values for Fonar (FONR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Fonar ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $0.01B | $0.16B | 7.12% |
| 2023-12-31 | $0.01B | $0.16B | 8.50% |
| 2023-09-30 | $0.01B | $0.15B | 7.28% |
| 2023-06-30 | $0.01B | $0.15B | 6.03% |
| 2023-03-31 | $0.01B | $0.15B | 6.76% |
| 2022-12-31 | $0.01B | $0.15B | 5.47% |
| 2022-09-30 | $0.01B | $0.15B | 6.91% |
| 2022-06-30 | $0.01B | $0.15B | 8.41% |
| 2022-03-31 | $0.01B | $0.14B | 7.86% |
| 2021-12-31 | $0.01B | $0.14B | 9.44% |
| 2021-09-30 | $0.01B | $0.14B | 8.87% |
| 2021-06-30 | $0.01B | $0.14B | 7.55% |
| 2021-03-31 | $0.01B | $0.14B | 7.68% |
| 2020-12-31 | $0.01B | $0.13B | 5.47% |
| 2020-09-30 | $0.01B | $0.13B | 5.54% |
| 2020-06-30 | $0.01B | $0.13B | 6.40% |
| 2020-03-31 | $0.01B | $0.13B | 8.94% |
| 2019-12-31 | $0.01B | $0.13B | 11.67% |
| 2019-09-30 | $0.01B | $0.12B | 12.04% |
| 2019-06-30 | $0.01B | $0.12B | 12.47% |
| 2019-03-31 | $0.02B | $0.11B | 17.55% |
| 2018-12-31 | $0.02B | $0.11B | 17.48% |
| 2018-09-30 | $0.02B | $0.11B | 19.39% |
| 2018-06-30 | $0.02B | $0.10B | 20.49% |
| 2018-03-31 | $0.02B | $0.09B | 18.18% |
| 2017-12-31 | $0.02B | $0.09B | 22.75% |
| 2017-09-30 | $0.02B | $0.09B | 24.28% |
| 2017-06-30 | $0.02B | $0.08B | 25.94% |
| 2017-03-31 | $0.02B | $0.08B | 28.04% |
| 2016-12-31 | $0.02B | $0.07B | 25.20% |
| 2016-09-30 | $0.02B | $0.07B | 24.90% |
| 2016-06-30 | $0.02B | $0.06B | 26.32% |
| 2016-03-31 | $0.01B | $0.06B | 25.69% |
| 2015-12-31 | $0.01B | $0.06B | 25.12% |
| 2015-09-30 | $0.01B | $0.05B | 23.88% |
| 2015-06-30 | $0.01B | $0.05B | 22.45% |
| 2015-03-31 | $0.01B | $0.05B | 20.94% |
| 2014-12-31 | $0.01B | $0.05B | 21.39% |
| 2014-09-30 | $0.01B | $0.05B | 22.35% |
| 2014-06-30 | $0.01B | $0.05B | 23.39% |
| 2014-03-31 | $0.01B | $0.04B | 24.54% |
| 2013-12-31 | $0.01B | $0.04B | 23.23% |
| 2013-09-30 | $0.01B | $0.04B | 25.20% |
| 2013-06-30 | $0.01B | $0.04B | 28.00% |
| 2013-03-31 | $0.00B | $0.04B | 21.92% |
| 2012-12-31 | $0.00B | $0.01B | 32.65% |
| 2012-09-30 | $0.00B | $0.01B | 36.36% |
| 2012-06-30 | $0.00B | $0.01B | 42.11% |
| 2012-03-31 | $0.00B | $0.01B | 36.36% |
| 2011-12-31 | $0.00B | $0.01B | 57.14% |
| 2011-09-30 | $0.00B | $0.01B | 150.00% |
| 2011-06-30 | $0.00B | $0.01B | -200.00% |
| 2011-03-31 | $0.00B | $-0.00B | -50.00% |
| 2010-12-31 | $0.00B | $-0.00B | -19.05% |
| 2010-09-30 | $-0.00B | $-0.01B | 17.39% |
| 2010-06-30 | $-0.00B | $-0.01B | 52.17% |
| 2010-03-31 | $-0.00B | $-0.01B | 60.00% |
| 2009-12-31 | $-0.00B | $-0.01B | 47.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.100B | $0.099B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.053B | 23.84 |
| Stryker (SYK) | United States | $129.729B | 31.07 |
| Boston Scientific (BSX) | United States | $112.966B | 35.98 |
| Medtronic (MDT) | Ireland | $101.722B | 15.23 |
| EssilorLuxottica (ESLOY) | France | $99.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.384B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.493B | 28.10 |
| ResMed (RMD) | United States | $28.144B | 26.42 |
| Terumo (TRUMY) | Japan | $24.477B | 34.57 |
| Koninklijke Philips (PHG) | Netherlands | $23.276B | 18.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.297B | 14.24 |
| Baxter (BAX) | United States | $17.081B | 12.15 |
| Insulet (PODD) | United States | $14.497B | 64.28 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $9.620B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.758B | 25.37 |
| BellRing Brands (BRBR) | United States | $7.565B | 35.58 |
| Lantheus Holdings (LNTH) | United States | $5.636B | 14.04 |
| Haemonetics (HAE) | United States | $4.238B | 20.90 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.54 |
| Perrigo (PRGO) | Ireland | $3.467B | 10.51 |
| Neogen (NEOG) | United States | $3.457B | 33.25 |
| ICU Medical (ICUI) | United States | $2.893B | 25.53 |
| Envista Holdings (NVST) | United States | $2.832B | 11.69 |
| TG Therapeutics (TGTX) | United States | $2.774B | 78.04 |
| Green Thumb Industries (GTBIF) | United States | $2.724B | 53.33 |
| Agios Pharmaceuticals (AGIO) | United States | $2.476B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.246B | 12.47 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.784B | 0.00 |
| Warby Parker (WRBY) | United States | $1.611B | 0.00 |
| InMode (INMD) | Israel | $1.517B | 8.06 |
| Verano Holdings (VRNOF) | United States | $1.455B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.76 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| Owens & Minor (OMI) | United States | $1.051B | 9.16 |
| National Vision Holdings (EYE) | United States | $0.995B | 31.67 |
| BioLife Solutions (BLFS) | United States | $0.944B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.871B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.697B | 14.83 |
| Evolus (EOLS) | United States | $0.684B | 0.00 |
| PetIQ (PETQ) | United States | $0.659B | 21.31 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.598B | 14.06 |
| Canopy Growth (CGC) | Canada | $0.508B | 0.00 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| ZimVie (ZIMV) | United States | $0.480B | 40.91 |
| Biote (BTMD) | United States | $0.458B | 10.56 |
| TerrAscend (TSNDF) | Canada | $0.426B | 0.00 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Zynex (ZYXI) | United States | $0.287B | 39.26 |
| Ayr Wellness (AYRWF) | United States | $0.266B | 0.00 |
| MacroGenics (MGNX) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.251B | 24.89 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.86 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 21.57 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.100B | 0.00 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Bright Green (BGXX) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
| Allurion Technologies (ALUR) | United States | $0.062B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.47 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |